News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
HAEMATO AG, 100% subsidiary of M1 Kliniken AG, sells HAEMATO Pharm GmbH to PHOENIX group. Transaction details undisclosed. M1 Kliniken AG aims for global leadership in medical aesthetics -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH has published a research update on M1 Kliniken AG, reaffirming a buy rating with a target price of EUR 28. Recent financial performance and strategic outlook support the positive assessment -
-